Finerenone - Isotope Labelled Standards
References
FAQ's
References
- Baerfacker, Lars; Kolkhof, Peter; Schlemmer, Karl-Heinz; Grosser, Rolf; Nitsche, Adam, Substituted 4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof, EP2132206B1, April 1, 2015, Bayer Healthcare A.-G.Germany
- Arulselvan Murugesan and Annapurna Mukthinuthalapati Mathrusri, Forced Degradation Studies for Estimation of Finerenone by RP-HPLC Method, Acta Scientific Pharmaceutical Sciences (ISSN: 2581-5423), Volume 5 Issue 12 December 2021
Frequently Asked Questions
How do Finerenone impurities form?
By-products that appear during the manufacture or improper storage of Finerenone can lead to the formation of Finerenone impurities.
Which analytic method detects Finerenone impurities?
RP-HPLC analytical methods help detect Finerenone impurities.
What is the use of Finerenone impurities?
Finerenone impurities help in pharmaceutical research, method validation, and stability studies.
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.